Humacyte HUMA
NASDAQ HUMA
$0.57 -0.01 (-1.43%)
As of: Sep 10, 2026 · 2:49 PM EDT

Humacyte (HUMA) Debt Ratio (2020 - 2026)

Humacyte's (HUMA) quarterly Debt Ratio came in at 0.26 in Q2 2026, down 46.73% year-over-year from 0.49 in Q2 2025, and down 18.93% quarter-over-quarter from 0.32 in Q1 2026.

Analysis

Humacyte (HUMA) Debt Ratio (2020 - 2026) Analysis & Trends

Humacyte (HUMA) has reported Debt Ratio for 7 consecutive years, with 0.26 the latest figure, recorded in Q2 2026.

  • On a quarterly basis, Debt Ratio fell 46.73% year-over-year to 0.26 in Q2 2026; TTM through Jun 2026 was 0.26, a 46.73% decrease from a year earlier, with the FY2025 full-year figure at 0.3, up 4645.14% from the prior year.
  • Debt Ratio was 0.26 for Q2 2026 at Humacyte, down from 0.32 in the prior quarter.
  • Over five years, Debt Ratio peaked at 0.54 in Q3 2024 and troughed at 0.01 in Q4 2024.
  • A 5-year average of 0.27 and a median of 0.26 in 2023 frame the typical range for Debt Ratio.
  • Across the five-year window, Debt Ratio jumped 114092.45% in 2022 and plunged 97.87% in 2024, its largest moves.
  • Over 5 years, Debt Ratio stood at 0.14 in 2022, then soared by 112.76% to 0.3 in 2023, then sank by 97.87% to 0.01 in 2024, then surged by 4645.14% to 0.3 in 2025, then retreated by 13.64% to 0.26 in 2026.
  • The last three Debt Ratio figures came in at 0.26 (Q2 2026), 0.32 (Q1 2026), and 0.3 (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Debt Ratio (Qtr)
1 Krystal Biotech 10.21 Bn 9.36 Bn 112.79 Mn -
2 CRISPR Therapeutics AG 5.02 Bn 5.02 Bn - 0.22
3 Iovance Biotherapeutics 3.64 Bn 3.34 Bn 55.72 Mn -
4 Legend Biotech 3.53 Bn 2.57 Bn 251.50 Mn 0.09
5 uniQure 2.98 Bn 2.98 Bn 5.49 Mn 0.05
6 Beam Therapeutics 2.53 Bn 2.53 Bn - 0.08
7 Precigen 2.39 Bn 2.39 Bn 52.17 Mn 0.55
8 Sarepta Therapeutics 2.15 Bn 1.35 Bn 251.87 Mn 0.27
9 Vericel 1.93 Bn 1.76 Bn 56.40 Mn -
10 Humacyte 133.72 Mn 133.72 Mn -825,000.00 0.26
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 0.26
Mar 31, 2026 0.32
Dec 31, 2025 0.30
Sep 30, 2025 0.23
Jun 30, 2025 0.49
Mar 31, 2025 0.41
Dec 31, 2024 0.01
Sep 30, 2024 0.54
Jun 30, 2024 0.43
Mar 31, 2024 0.36
Dec 31, 2023 0.30
Sep 30, 2023 0.25
Jun 30, 2023 0.22
Mar 31, 2023 0.16
Dec 31, 2022 0.14
Sep 30, 2022 0.13
Jun 30, 2022 0.12
Mar 31, 2022 0.11
Dec 31, 2021 0.10
Sep 30, 2021 0.06